Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | SCN1A | P35498 | 2/20 | 0.38 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.38 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL28490442 | 0.95 | UTS2R (0.45) | UTS2RKMT2ATSHRALDH1A1LMNA | |
| SCHEMBL1513963 | 0.89 | TSHR (0.53) | KMT2ATSHRALDH1A1LMNACYP3A4 | |
| SCHEMBL28102299 | 0.85 | KMT2A (0.48) | KMT2ATSHRALDH1A1LMNACYP3A4 | |
| SCHEMBL27713909 | 0.84 | UTS2R (0.49) | UTS2RKMT2ATSHRALDH1A1LMNA | |
| SCHEMBL29267594 | 0.84 | KMT2A (0.38) | UTS2RKMT2ATSHRALDH1A1LMNA | |
| SCHEMBL10591636 | 0.83 | TSHR (0.52) | TSHRALDH1A1LMNACYP3A4CA2 | |
| SCHEMBL28362466 | 0.83 | LMNA (0.55) | KMT2ATSHRALDH1A1LMNACA2 | |
| SCHEMBL27637585 | 0.83 | SMN1; SMN2 (0.48) | UTS2RKMT2ATSHRALDH1A1LMNA | |
| SCHEMBL1513969 | 0.83 | ALDH1A1 (0.56) | KMT2ATSHRALDH1A1LMNACYP3A4 | |
| SCHEMBL873754 | 0.83 | TSHR (0.50) | KMT2ATSHRALDH1A1LMNACA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1728995-A | Dosage forms comprising a cetp inhibitor and an HMG-CoA reductase inhibitor | PFIZER PROD INC (US) | 2006-02-01 | — | — | CN | claimed |
| CN-1545421-A | Pharmaceutical composition comprising a low-solubility and/or acid-sensitive drug and a neutralized acidic polymer | �Ʒ� | 2004-11-10 | — | — | CN | claimed |
| CN-1523979-A | Pharmaceutical compositions of adsorbates of amorphous drug | �Ʒ� | 2004-08-25 | — | — | CN | claimed |
| CN-1418089-A | Pharmaceutical composition of glycogen phosphorylase inhibitor | PFIZER PROD INC (US) | 2003-05-14 | — | — | CN | claimed |
| CN-1402629-A | Pharmaceutical compositions providing enhanced drug concentrations | PFIZER PROD INC (US) | 2003-03-12 | — | — | CN | claimed |
| CN-107303278-B | HC-1119 solid dispersion and preparation method thereof | 成都海创药业有限公司 | 2020-11-13 | — | — | CN | disclosed |
| CN-107548302-A | Viscosity building compositions for personal care products | 奥麒个人护理产品有限合伙公司 | 2018-01-05 | — | — | CN | disclosed |
| CN-102802608-A | Dosage forms of apixaban | PFIZER | 2012-11-28 | — | — | CN | disclosed |
| CN-102695413-A | Stable fatty acid formulations | MYCELL HOLDINGS LTD | 2012-09-26 | — | — | CN | disclosed |
| CN-102026612-A | Modification of particulate-stabilised fluid-fluid interfaces | UNILEVER PLC | 2011-04-20 | — | — | CN | disclosed |
| CN-101573110-A | Methods of lowering glucose levels | SANOFI AVENTIS DEUTSCHLAND (DE) | 2009-11-04 | — | — | CN | disclosed |
| CN-101175477-A | Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same | KING PHARMACEUTICALS RES & DEV (US) | 2008-05-07 | — | — | CN | disclosed |
| CN-1688291-A | Immediate release dosage forms containing solid drug dispersions | PFIZER (US) | 2005-10-26 | — | — | CN | disclosed |
| CN-1681479-A | Pharmaceutical compositions of semi-ordered drugs and polymers | PFIZER PROD INC (US) | 2005-10-12 | — | — | CN | disclosed |
| CN-1625397-A | Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor | PFIZER PROD INC (US) | 2005-06-08 | — | — | CN | disclosed |
| CN-1545421-A | Pharmaceutical composition comprising a low-solubility and/or acid-sensitive drug and a neutralized acidic polymer | �Ʒ� | 2004-11-10 | — | — | CN | disclosed |
| CN-1523979-A | Pharmaceutical compositions of adsorbates of amorphous drug | �Ʒ� | 2004-08-25 | — | — | CN | disclosed |
| CN-1458840-A | Pharmaceutical composition of cholesteryl ester transfer protein inhibitor | PFIZER PROD INC (US) | 2003-11-26 | — | — | CN | disclosed |
| CN-1418089-A | Pharmaceutical composition of glycogen phosphorylase inhibitor | PFIZER PROD INC (US) | 2003-05-14 | — | — | CN | disclosed |
| CN-1402629-A | Pharmaceutical compositions providing enhanced drug concentrations | PFIZER PROD INC (US) | 2003-03-12 | — | — | CN | disclosed |